Cancer Analysis & Statistics

1354 results
Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032 New
Extensive Stage Small Cell Lung Cancer Market - A Global and Regional Analysis: Focus on Epidemiology, Product, and Region - Analysis and Forecast, 2022-2032

Regionally, according to BIS Research estimates about the target patient pool of extensive stage small cell lung cancer, the U.S. and the U.K. occupy the top position among the seven major markets, fo…

  • World
  • Lung Cancer
  • Industry analysis
Global Oncology Partnering 2015-2022: Deal trends, players and financials New
Global Oncology Partnering 2015-2022: Deal trends, players and financials

The Global Oncology Partnering 2015-2022: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds lea…

  • World
  • Cancer
  • Industry analysis
Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 New
Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

Computer Aided Detection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Imaging Modality (Mammography, MRI, Ultrasound, Tomosynthesis, Others), By Appl…

  • World
  • United States
  • Chronic Disease
  • Healthcare
  • Industry analysis
  • Computer Expenditure
  • Health Provider Density
Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 New
Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

Human Papillomavirus Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Valence (Bivalent, Quadrivalent, Nonvalent, Others), By Disease Indication …

  • World
  • Vaccine
  • Cancer
  • Industry analysis
Hospital Asset Tracking and Inventory Management Systems Global Market Report 2022: Ukraine-Russia War Impact New
Hospital Asset Tracking and Inventory Management Systems Global Market Report 2022: Ukraine-Russia War Impact

Major players in the hospital asset tracking and inventory management systems market are ZIH Corp, Ascom, GE Healthcare (General Electric Company), CenTrak (Halma plc), Honeywell International Inc., A…

  • World
  • United States
  • Location Based Service
  • Marketing Research
  • Industry analysis
  • Cancer Incidence
2022-2027 Asia-Pacific Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor New
2022-2027 Asia-Pacific Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor

2022-2027 Asia-Pacific Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- An 18-Country Database and Analys…

  • APAC
  • Breast Cancer
  • Diagnostics
  • Industry analysis
2022-2027 Latin America Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor New
2022-2027 Latin America Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor

2022-2027 Latin America Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- A 22-Country Database and Analys…

  • Latin America
  • Breast Cancer
  • Diagnostics
  • Industry analysis
2022-2027 Middle East Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor New
2022-2027 Middle East Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor

2022-2027 Middle East Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- An 11-Country Database and Analysi…

  • Middle East
  • Breast Cancer
  • Diagnostics
  • Industry analysis
2022-2027 North America Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--US, Canada, Mexico New
2022-2027 North America Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--US, Canada, Mexico

2022-2027 North America Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--US, Canada, Mexico--2022 Supplier…

  • North America
  • World
  • Breast Cancer
  • Diagnostics
  • Industry analysis
2022-2027 Global Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--US, Europe, Japan New
2022-2027 Global Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--US, Europe, Japan

2022-2027 Global Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--US, Europe, Japan--2022 Supplier Shares …

  • World
  • Europe
  • Breast Cancer
  • Diagnostics
  • Industry analysis
2022-2027 Europe Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--France, Germany, Italy, Spain, UK New
2022-2027 Europe Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--France, Germany, Italy, Spain, UK

2022-2027 Europe Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--France, Germany, Italy, Spain, UK--2022 …

  • Europe
  • Spain
  • Breast Cancer
  • Diagnostics
  • Industry analysis
North America Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User New
North America Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

The embolotherapy market in North America is expected to grow from US$ 1,354.02 million in 2022 to US$ 2,245.73 million by 2028. It is estimated to grow at a CAGR of 8.8% from 2022 to 2028. Rising Pr…

  • North America
  • United States
  • Cancer
  • Industry analysis
  • Cancer Incidence
  • Surgical Procedures Performed
South & Central America Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User New
South & Central America Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

The embolotherapy market in South & Central America is expected to grow from US$ 230.83 million in 2022 to US$ 339.16 million by 2028. It is estimated to grow at a CAGR of 6.6% from 2022 to 2028. Ris…

  • Central America
  • Healthcare
  • Cancer
  • Industry analysis
  • Cancer Incidence
  • Surgical Procedures Performed
Asia-Pacific Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User New
Asia-Pacific Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

The embolotherapy market in Asia Pacific is expected to grow from US$ 781.80 million in 2022 to US$ 1,272.58 million by 2028. It is estimated to grow at a CAGR of 8.5% from 2022 to 2028. Growing Use …

  • APAC
  • Cancer
  • Cardiovascular Disease
  • Industry analysis
  • Chronic Disease Prevalence
  • Health Expenditure
Europe Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User New
Europe Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

The embolotherapy market in Europe is expected to grow from US$ 1,050.81 million in 2022 to US$ 1,638.92 million by 2028. It is estimated to grow at a CAGR of 7.7% from 2022 to 2028. Rising Prevalenc…

  • Europe
  • Cancer
  • Pathology
  • Industry analysis
  • Cancer Incidence
  • Health Expenditure
Middle East & Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User New
Middle East & Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product, Disease Indication, Procedure, and End User

The embolotherapy market in the Middle East & Africa is expected to grow from US$ 183.66 million in 2022 to US$ 261.89 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028. Wi…

  • Middle East
  • Africa
  • Cancer
  • Industry analysis
  • Cancer Incidence
  • Mortality Rate
Global Lung Cancer Therapeutics Market 2023-2027 New
Global Lung Cancer Therapeutics Market 2023-2027

Global Lung Cancer Therapeutics Market 2023-2027 The analyst has been monitoring the lung cancer therapeutics market and it is poised to grow by $10204.33 mn during 2023-2027, accelerating at a CAGR o…

  • World
  • Lung Cancer
  • Industry analysis
Asia-Pacific Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End-use Industry New
Asia-Pacific Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End-use Industry

The APAC asparaginase market is expected to grow from US$ 132.43 million in 2022 to US$ 341.39 million by 2028; it is estimated to grow at a CAGR of 17.1% from 2022 to 2028. Increase in Pharmaceutica…

  • APAC
  • Cancer
  • Pharmaceutical
  • Industry analysis
  • Cancer Incidence
  • Health Expenditure
Europe Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End-use Industry New
Europe Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End-use Industry

The Europe asparaginase market is expected to grow from US$ 189.17 million in 2022 to US$ 451.68 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2022 to 2028. Use of Asparaginase in …

  • Europe
  • Leukemia
  • Healthcare
  • Industry analysis
  • Final Consumption Expenditures
  • Health Expenditure
Middle East & Africa Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End-use Industry New
Middle East & Africa Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End-use Industry

The MEA asparaginase market is expected to grow from US$ 22.60 million in 2022 to US$ 48.37 million by 2028; it is estimated to grow at a CAGR of 13.5% from 2022 to 2028. New Product Launches and App…

  • South Africa
  • Saudi Arabia
  • Leukemia
  • Healthcare
  • Industry analysis
  • Cancer Incidence
  • Health Expenditure
North America Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End-use Industry New
North America Asparaginase Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Type, Application, and End-use Industry

The North America asparaginase market is expected to grow from US$ 267.71 million in 2022 to US$ 660.94 million by 2028; it is estimated to grow at a CAGR of 16.3% from 2022 to 2028. Rising Applicati…

  • North America
  • Leukemia
  • Healthcare
  • Industry analysis
  • Food Consumption
  • Health Expenditure
Cancer/Tumor Profiling Market by Technology, Cancer Type, Biomarker Type, Application - Global Forecast to 2027 New
Cancer/Tumor Profiling Market by Technology, Cancer Type, Biomarker Type, Application - Global Forecast to 2027

The global cancer/tumor profiling market is projected to reach USD 16.0 Billion by 2027 from USD 9.7 Billion in 2022, at a CAGR of 10.6% during the forecast period. Growth in this market is majorly dr…

  • World
  • United States
  • Cancer
  • Industry analysis
  • Cancer Incidence
  • Health Expenditure
CAR-T Therapy Market Report 2022-2032 New
CAR-T Therapy Market Report 2022-2032

Forecasts by Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukaemia (ALL), Follicular Lymphoma, Multiple Myeloma (MM), Other), by Type (Abecma, Yescarta, Kymriah, Tecartus, O…

  • World
  • Cancer
  • Immunotherapy
  • Industry analysis
  • Cancer Incidence
  • Cancer Mortality
Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 New
Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027

Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital He…

  • World
  • Cancer
  • Therapy
  • Industry analysis
Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Drug Class, By Tumor Type, By Distribution Channel, By Region New
Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Drug Class, By Tumor Type, By Distribution Channel, By Region

Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Drug Class (Alkylating Agents, Mitotic Inhibitors, Antirheumatics, Antipsoriatics, …

  • World
  • Ovarian Cancer
  • Industry analysis
  • Cancer Incidence
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update New
Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Kaposi Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Kaposi Sarcoma - D…

  • World
  • Cancer
  • Industry analysis
  • Prescription Drug Sales
  • Cancer Mortality
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update New
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Heal…

  • World
  • Leukemia
  • Industry analysis
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update New
Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Chronic Lymphocytic Leukemia (CLL) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guid…

  • World
  • Leukemia
  • Industry analysis
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update New
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthc…

  • World
  • Leukemia
  • Industry analysis
  • Drug Approval
  • Stem Cell Transplantation
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update New
Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin …

  • World
  • Lymphoma
  • Industry analysis